Mayne Pharma Group Ltd (MYX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Sales | 140,324 | 142,181 | 82,262 | 50,897 | 48,504 |
| Cost of Goods | 61,433 | 68,203 | 44,441 | 29,342 | 26,861 |
| Gross Profit | 78,891 | 73,978 | 37,821 | 21,555 | 21,643 |
| Operating Expenses | 70,023 | 50,345 | 31,845 | 19,023 | 22,460 |
| Operating Income | 8,868 | 23,633 | 5,976 | 2,532 | -817 |
| Interest Expense | 5,945 | 4,349 | 2,306 | 28 | 1,812 |
| Other Income | 8,320 | 8,738 | -4,373 | 5,247 | 1,125 |
| Pre-tax Income | 11,243 | 28,022 | -703 | 7,751 | -1,504 |
| Income Tax | 3,706 | 6,732 | 2,140 | 1,598 | -3,183 |
| Net Income Continuous | 7,537 | 21,290 | -2,843 | 6,153 | 1,679 |
| Minority Interests | 222 | N/A | N/A | N/A | N/A |
| Net Income | $7,759 | $21,290 | $-2,843 | $6,153 | $1,679 |
| EPS Basic Total Ops | 0.22 | 0.69 | -0.13 | 0.58 | 0.16 |
| EPS Basic Continuous Ops | 0.22 | 0.69 | -0.13 | 0.58 | 0.16 |
| EPS Diluted Total Ops | 0.22 | 0.66 | -0.13 | 0.58 | 0.16 |
| EPS Diluted Continuous Ops | 0.22 | 0.66 | -0.13 | 0.58 | 0.16 |
| EBITDA(a) | $30,690 | $42,230 | $8,933 | $13,367 | $8,059 |